Top Markets
Coin of the day
Neovacs S.A. Neovacs S.A.

Neovacs S.A.

ALNEV
Ранг среди акций #21228
Neovacs S.A., a biotechnology company, focuses on the development of... Neovacs S.A., a biotechnology company, focuses on the development of therapeutic vaccines for the treatment of autoimmune, inflammatory, allergy, and cancer diseases in France. It develops treatments for chronic autoimmune and inflammatory diseases using its proprietary Kinoid technology. The company's product pipeline includes IFNa Kinoid, an anti-interferon alpha vaccine that is in Phase IIb clinical trial for the treatment of systemic lupus erythematosus; Phase IIa clinical trial for the treatment of dermatomyositis; and preclinical stage for the treatment of diabetes. It is also developing VEGF-Kinoid, which is in preclinical stage for the treatment of age-related macular degeneration and solid tumors; and IL-4/IL-13 Kinoid that is in preclinical stage for the treatment of allergies. The company has a collaboration with the Sunnybrook Research Institute for preclinical development of VEGF Kinoid to treat colorectal and ovarian cancer. Neovacs S.A. was founded in 1993 and is based in Paris, France.
Цена акции
$0.00047446
Рыночная капитализация
$82.80
Изменение (1 день)
0.00%
Изменение (1 год)
-98.16%
Страна
FR
Торговля Neovacs S.A. (ALNEV)

Категория

История дроблений акций Neovacs S.A. (ALNEV)
Акции Neovacs S.A. (символ: ALNEV) прошли через 6 дроблений.
Последнее дробление произошло Jul 18, 2025.
Одна акция ALNEV, купленная до Feb 01, 2022, сейчас соответствует 1.5625E-23 акциям ALNEV.
Список дроблений акций
Год Дробление Коэффициент Суммарный коэффициент
2025-07-18 1:1000 x0.001 x1.5625E-23
2024-12-05 1:10000 x0.0001 x1.5625E-20
2024-02-06 1:10000 x0.0001 x1.5625E-16
2023-06-05 1:8000 x0.000125 x1.5625E-12
2023-06-02 1:8000 x0.000125 x1.25E-8
2022-02-01 1:10000 x0.0001 x0.0001
Дробления акций аналогичных компаний или конкурентов
Компания Количество дроблений акций Суммарный коэффициент Страна
5 x199
DK
1 x2
US
0 -
US
0 -
BE
0 -
NL